Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data

Area of Science:

• Oncology
• Computational Biology
• Bioinformatics

Background:

• Personalized medicine is crucial for cancer treatment.
• Tumor heterogeneity presents a significant challenge to developing effective patient-specific therapies.
• Existing drugs often fail due to intra-tumor variations.

Purpose of the Study:

• To develop a computational approach for personalized cancer therapy.
• To address the challenge of intra-tumor heterogeneity in basal breast cancer.
• To identify optimal drug combinations for individual patients.

Main Methods:

• Integrated analysis of copy number alteration, gene expression, and protein interaction networks from 73 basal breast cancer samples.
• Survival analysis to identify 2509 prognostic genes with copy number alterations.
• Construction of a protein-protein interaction network to characterize patients by seven altered hub proteins.

Main Results:

• Identified 2509 prognostic genes associated with copy number alterations.
• Characterized each of the 73 basal breast cancer patients using a unique combination of seven altered hub proteins.
• Suggested optimal combination therapies for individual patients based on drug-protein interactions.
• Validated known cancer genes and proposed novel drug targets.

Conclusions:

• Presented a novel computational approach for personalized cancer therapy.
• Demonstrated a method to overcome intra-tumor heterogeneity in basal breast cancer.
• Paved the way for more effective, patient-specific cancer treatment strategies.